Last Updated: September 24, 2026

Details for Patent: 8,658,673


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,658,673
Title:BETA2-adrenoreceptor agonists
Abstract:Compounds of formula in free or salt or solvate form, where
Inventor(s):Bernard Cuenoud, Ian Bruce, Robin Alec Fairhurst, David Beattie
Assignee: Novartis AG
Application Number:US13/858,308
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;

Drugs Protected by US Patent 8,658,673

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,658,673

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9913083.3Apr 6, 1999

International Family Members for US Patent 8,658,673

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1183240 ⤷  Start Trial C300437 Netherlands ⤷  Start Trial
European Patent Office 1183240 ⤷  Start Trial CA 2010 00006 Denmark ⤷  Start Trial
European Patent Office 1183240 ⤷  Start Trial 91651 Luxembourg ⤷  Start Trial
European Patent Office 1183240 ⤷  Start Trial SPC009/2010 Ireland ⤷  Start Trial
European Patent Office 1183240 ⤷  Start Trial 10C0006 France ⤷  Start Trial
European Patent Office 1183240 ⤷  Start Trial SPC/GB10/009 United Kingdom ⤷  Start Trial
European Patent Office 1183240 ⤷  Start Trial C01183240/01 Switzerland ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.